- Home
- HROW vs ALX Comparison
HROW vs ALX Comparison
Compare HROW & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- ALX
- Stock Information
- Founded
- HROW 1998
- ALX 1928
- Country
- HROW United States
- ALX United States
- Employees
- HROW N/A
- ALX N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- ALX Real Estate Investment Trusts
- Sector
- HROW Health Care
- ALX Real Estate
- Exchange
- HROW Nasdaq
- ALX Nasdaq
- Market Cap
- HROW 1.4B
- ALX 1.2B
- IPO Year
- HROW N/A
- ALX N/A
- Fundamental
- Price
- HROW $45.09
- ALX $235.89
- Analyst Decision
- HROW Strong Buy
- ALX
- Analyst Count
- HROW 7
- ALX 0
- Target Price
- HROW $64.67
- ALX N/A
- AVG Volume (30 Days)
- HROW 506.9K
- ALX 45.8K
- Earning Date
- HROW 11-12-2025
- ALX 11-03-2025
- Dividend Yield
- HROW N/A
- ALX 7.67%
- EPS Growth
- HROW N/A
- ALX N/A
- EPS
- HROW N/A
- ALX 7.28
- Revenue
- HROW $227,661,000.00
- ALX $218,089,000.00
- Revenue This Year
- HROW $45.86
- ALX N/A
- Revenue Next Year
- HROW $41.41
- ALX N/A
- P/E Ratio
- HROW N/A
- ALX $32.44
- Revenue Growth
- HROW 47.69
- ALX N/A
- 52 Week Low
- HROW $20.85
- ALX $184.76
- 52 Week High
- HROW $59.23
- ALX $260.84
- Technical
- Relative Strength Index (RSI)
- HROW 74.17
- ALX 52.94
- Support Level
- HROW $42.23
- ALX $232.22
- Resistance Level
- HROW $44.07
- ALX $247.42
- Average True Range (ATR)
- HROW 1.76
- ALX 5.53
- MACD
- HROW 0.52
- ALX 0.42
- Stochastic Oscillator
- HROW 98.28
- ALX 48.89
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.